Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q3 2022
Institutional positions in Verona Pharma plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 68
- +29 vs. Q2 2022
- Shares held
- 52.1M
- +17.0M (+48.4%) vs. Q2 2022
- Total value
- $529.0M
- +$383.1M (+262.6%) vs. Q2 2022
- New holders
- 35
- 15 more added
- Sold out
- 6
- 7 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $1.00K | 0.00% | +100 | New |
| Advisor Group Holdings, Inc. | 346 | $3.00K | 0.00% | +346 | New |
| Cutler Group LP | 392 | $4.00K | 0.00% | +392 | New |
| Tower Research Capital LLC (TRC) | 553 | $6.00K | 0.00% | −1,573−74.0% | Reduced |
| Federation des caisses Desjardins du Quebec | 650 | $6.64K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 726 | $7.00K | 0.00% | +726 | New |
| UBS Group AG | 778 | $8.00K | 0.00% | +778 | New |
| Plante Moran Financial Advisors, LLC | 892 | $9.00K | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 1,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,380 | $14.0K | 0.00% | −297−17.7% | Reduced |
| Endurance Wealth Management, Inc. | 2,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,978 | $51.0K | 0.00% | −4,807−49.1% | Reduced |
| Group One Trading, L.P. | 5,217 | $53.0K | 0.00% | +5,138+6,503.8% | Added |
| Brinker Capital Investments, LLC | 12,326 | $126.0K | 0.00% | +12,326 | New |
| Forefront Analytics, LLC | 13,446 | $138.0K | 0.07% | −13,750−50.6% | Reduced |
| SEI Investments Co | 13,460 | $138.0K | 0.00% | +13,460 | New |
| HSBC Holdings PLC | 15,041 | $158.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 16,192 | $165.0K | 0.00% | +16,192 | New |
| Ikarian Capital, LLC | 315,131 | $193.0K | 0.10% | +15,131+5.0% | Added |
| Bank of New York Mellon Corp | 24,850 | $254.0K | 0.00% | +24,850 | New |
| Glenmede Trust Co NA | 30,215 | $308.0K | 0.00% | +30,215 | New |
| Goldman Sachs Group Inc | 36,360 | $372.0K | 0.00% | +24,767+213.6% | Added |
| D.A. Davidson & Co. | 40,000 | $409.0K | 0.01% | −4,500−10.1% | Reduced |
| AlphaCentric Advisors LLC | 40,000 | $409.0K | 0.42% | +40,000 | New |
| Jump Financial, LLC | 40,800 | $417.0K | 0.02% | +40,800 | New |
| Vanguard Group Inc | 41,704 | $426.0K | 0.00% | +41,704 | New |
| Geode Capital Management, LLC | 42,350 | $432.0K | 0.00% | +27,913+193.3% | Added |
| Cubist Systematic Strategies, LLC | 42,877 | $438.0K | 0.00% | +42,877 | New |
| US Bancorp | 46,095 | $471.0K | 0.00% | +42,255+1,100.4% | Added |
| Boothbay Fund Management, LLC | 46,799 | $478.0K | 0.02% | +8,519+22.3% | Added |
| Schonfeld Strategic Advisors LLC | 59,000 | $603.0K | 0.01% | +4,700+8.7% | Added |
| JPMorgan Chase & Co | 63,279 | $647.0K | 0.00% | +63,279 | New |
| 1492 Capital Management LLC | 65,862 | $673.0K | 0.49% | +65,862 | New |
| Millennium Management LLC | 79,340 | $811.0K | 0.00% | +79,340 | New |
| Pura Vida Investments, LLC | 100,000 | $1.02M | 0.15% | +100,000 | New |
| UBS Oconnor LLC | 111,926 | $1.14M | 0.01% | +111,926 | New |
| Sphera Funds Management Ltd. | 120,000 | $1.23M | 0.22% | +120,000 | New |
| ACT Capital Management, LLC | 143,500 | $1.47M | 2.02% | +143,500 | New |
| Two Sigma Advisers, LP | 153,400 | $1.57M | 0.00% | +153,400 | New |
| Renaissance Technologies LLC | 210,100 | $2.15M | 0.00% | +181,900+645.0% | Added |
| Moody Aldrich Partners LLC | 227,989 | $2.33M | 0.48% | +227,989 | New |
| ExodusPoint Capital Management, LP | 239,602 | $2.45M | 0.03% | +239,602 | New |
| Janus Henderson Group PLC | 300,000 | $3.07M | 0.00% | +300,000 | New |
| Parkman Healthcare Partners LLC | 323,273 | $3.30M | 0.94% | +323,273 | New |
| Affinity Asset Advisors, LLC | 350,000 | $3.58M | 1.65% | +350,000 | New |
| Two Sigma Investments, LP | 360,550 | $3.69M | 0.01% | +360,550 | New |
| Woodline Partners LP | 375,033 | $3.83M | 0.06% | −126,425−25.2% | Reduced |
| Altium Capital Management LP | 404,000 | $4.13M | 1.55% | +404,000 | New |
| FMR LLC | 413,400 | $4.22M | 0.00% | +413,400 | New |
| State Street Corp | 449,029 | $4.23M | 0.00% | +449,029 | New |
| Adage Capital Partners GP, L.L.C. | 431,816 | $4.41M | 0.01% | +431,816 | New |
| Citadel Advisors LLC | 695,260 | $7.11M | 0.01% | +684,511+6,368.1% | Added |
| Samsara BioCapital, LLC | 938,890 | $9.60M | 2.24% | −172,222−15.5% | Reduced |
| Foresite Capital Management III, LLC | 1,111,112 | $11.4M | 29.98% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,324,868 | $13.5M | 2.34% | +1,324,868 | New |
| Aisling Capital Management LP | 1,332,485 | $13.6M | 9.04% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,099,541 | $21.5M | 1.65% | +2,099,541 | New |
| Abingworth LLP | 2,457,500 | $25.1M | 8.58% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 2,678,982 | $27.4M | 5.05% | +1,752,380+189.1% | Added |
| Deep Track Capital, LP | 2,829,094 | $28.9M | 1.43% | +2,829,094 | New |
| Wellington Management Group LLP | 4,177,276 | $42.7M | 0.01% | +349,127+9.1% | Added |
| Vivo Capital, LLC | 4,249,918 | $43.4M | 4.80% | +1,500,000+54.5% | Added |
| Perceptive Advisors LLC | 5,047,264 | $51.6M | 1.50% | +2,132,118+73.1% | Added |
| NEA Management Company, LLC | 5,584,753 | $57.1M | 2.85% | +476,190+9.3% | Added |
| OrbiMed Advisors LLC | 5,694,841 | $58.2M | 1.16% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 6,050,000 | $61.8M | 1.32% | +950,000+18.6% | Added |
| Novo Holdings A/S | 0 | $0 | 0.00% | −761,205−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −751,905−100.0% | Sold out |
| venBio Partners LLC | 0 | $0 | 0.00% | −161,897−100.0% | Sold out |
| IPG Investment Advisors LLC | 0 | $0 | 0.00% | −11,900−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,866−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Brewin Dolphin Ltd | – | – | – | – | Not filed |